Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COLBENEMID | Merck & Co | N-012383 DISCN | 1982-01-01 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MITIGARE | Hikma Pharmaceuticals | N-204820 RX | 2014-09-26 | 1 products, RLD, RS |
GLOPERBA | Scilex Pharmaceuticals | N-210942 RX | 2019-01-30 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
colchicine | ANDA | 2025-03-27 |
colcrys | New Drug Application | 2023-12-29 |
gloperba | New Drug Application | 2024-11-01 |
lodoco | New Drug Application | 2024-08-09 |
mitigare | New Drug Application | 2024-05-16 |
probenecid and colchicine | ANDA | 2023-11-06 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Colchicine, Gloperba, Scilex Pharms | |||
10226423 | 2037-12-20 | DP | |
9907751 | 2036-11-22 | DP | |
10383820 | 2036-11-22 | DP | U-2814 |
10383821 | 2036-11-22 | DP | |
Colchicine, Lodoco, Agepha Pharma Fz | |||
9744144 | 2035-01-22 | U-3643 | |
10206891 | 2035-01-22 | U-3641 | |
10265281 | 2035-01-22 | U-3639 | |
10842762 | 2035-01-22 | U-3640 | |
11026899 | 2035-01-22 | U-3639 | |
11026900 | 2035-01-22 | U-3639 | |
11026901 | 2035-01-22 | U-3638 | |
10130585 | 2034-12-31 | U-3642 | |
Colchicine, Mitigare, Hikma Intl Pharms | |||
8927607 | 2033-08-22 | U-1020 | |
9399036 | 2033-08-22 | U-1020 | |
9555029 | 2033-08-22 | U-1020 | |
9675613 | 2033-08-22 | U-1020 | |
9789108 | 2033-08-22 | U-1020 | |
Colchicine, Colcrys, Takeda Pharms Usa | |||
7820681 | 2029-02-17 | U-1020 | |
7906519 | 2029-02-17 | U-1116 | |
7915269 | 2029-02-17 | U-1007 | |
8440721 | 2029-02-17 | U-1007 | |
8440722 | 2029-02-17 | U-1020 | |
7601758 | 2029-02-10 | U-1007 | |
7619004 | 2028-12-03 | U-1020 | |
7935731 | 2028-12-03 | U-1116 | |
7964647 | 2028-10-06 | U-1007 | |
7964648 | 2028-10-06 | U-1161 | |
7981938 | 2028-10-06 | U-1166 | |
8093296 | 2028-10-06 | U-1007 | |
8093297 | 2028-10-06 | U-1161 | |
8093298 | 2028-10-06 | U-1116 | |
8097655 | 2028-10-06 | U-1020 | |
8415395 | 2028-10-06 | U-1007 | |
8415396 | 2028-10-06 | U-1007 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | 1 | — | 1 |
Fibrosis | D005355 | — | — | — | — | — | 1 | — | 1 |
Hepatitis c | D006526 | — | B19.2 | — | — | — | 1 | — | 1 |
Hepatitis | D006505 | — | K75.9 | — | — | — | 1 | — | 1 |
Hepacivirus | D016174 | — | — | — | — | — | 1 | — | 1 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | — | — | 1 | — | 1 |
Drug common name | Colchicine |
INN | — |
Description | (S)-colchicine is a colchicine that has (S)-configuration. It is a secondary metabolite, has anti-inflammatory properties and is used to treat gout, crystal-induced joint inflammation, familial Mediterranean fever, and many other conditions. It has a role as a mutagen, an anti-inflammatory agent and a gout suppressant. It is a colchicine and an alkaloid. It is an enantiomer of a (R)-colchicine. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2 |